O3 Prime™

Yes, but in order to get in the optimal dose of 1-2 grams of EPA/DHA, you’d have to consume the equivalent of around 1 serving (roughly 100 grams) of fatty fish every day, which is quite uncommon for most people.

Not only that, but eating high amounts of fish rich in omega 3’s also increases your risk of consuming excessive heavy metals and other environmental toxins.

This makes fish oil supplementation a great option for getting in your daily EPA/DHA requirements without potentially putting your health at risk.

Some benefits of O3 Prime can be directly “felt”, while others provide overall long-term benefits that work more “beneath the hood” and won’t be quite as obvious.

Examples of benefits that you may directly feel after a few weeks of supplementation include improvements in mood and well-being, increased mental clarity, reduced muscle soreness and better joint health.

Just how strongly these effects are experienced largely depends on what your EPA/DHA levels were prior to supplementation, as well as individual factors.

Examples of benefits that you won’t necessarily “feel” but may experience symptoms of longer term include improved heart health, body composition, immune function and bone health just to name a few.

While supplementing with fish oil certainly isn’t going to add two inches to your arms or 50 pounds to your bench press overnight, it can help to optimize your results over the long term when used in combination with proper training and diet.

This is because fish oil is research supported to:

Increase activation of the mTOR pathway, a central trigger of protein synthesis. [47-48]
Reduce muscle breakdown by lowering cortisol levels. [49-51]
Improve fatty acid oxidation and insulin sensitivity. [52-58]
Decrease muscle soreness for better recovery and performance. [59-60]
Alleviate inflammatory joint pain for improved training longevity. [61]

While it’s impossible to create a fish oil supplement with zero contaminants (since these substances are simply found in the environment and can’t be completely avoided), it is possible to keep the amounts at a fully minimized level that is safe for consumption.

Studies have shown that small, cold-water, non-predatory fish provide the purest source of oil available with the lowest level of contaminants possible. [71-74]

That’s why O3 Prime is sourced from deepwater Icelandic anchovy and is processed using enhanced “molecular distillation” to ensure that you’re getting a fully purified end-product you can trust.

O3 Prime meets the strict standards set by the Global Organization for EPA and DHA Omega-3 (GOED), the Council for Responsible Nutrition (CRN), and the European Pharmacopoeia Reference Standards (EPRS) by providing:

Fewer than 0.1 parts per million of heavy metals.
Fewer than 1.75 parts per trillion of dioxins.
Fewer than 1 part per trillion of dioxin-like PCBs.
Fewer than 0.09 parts per million of total PCBs.

We recommend 2-4 total grams of O3 Prime per day, ideally split into two dosages taken in the morning and/or afternoon with food.

Although fish oil is not a stimulant, it does increase brain activity and so a slight stimulatory effect may be felt after supplementation.

The research on this topic is fairly mixed and inconclusive at this point. Some studies have shown slightly higher absorption rates with krill oil, while others have failed to replicate these findings.

Given the huge amount of research that already supports fish oil’s benefits along with the significantly higher price of krill oil, we felt that fish oil was the smarter option for O3 Prime.

Since O3 Prime is delivered in the leading re-esterified triglyceride form (which is less susceptible to rancidification than the commonly sold ethyl ester form) and is provided in softgels coated with natural lemon flavoring, the chances of fish burps are very unlikely as long as you consume it alongside food.

If you do experience this problem, keeping the bottle in the freezer and splitting your dosage up throughout the day should eliminate it.

03 Prime is delivered in medium sized softgels that are lightly coated for easy swallowing.

Although refrigerating O3 Prime will technically extend its shelf life, it shouldn’t be necessary since each bottle provides a 1-2 month supply and is stable at room temperature for up to 2 years.

Some benefits of O3 Prime can be directly “felt”, while others provide overall long-term benefits that work more “beneath the hood” and won’t be quite as obvious.

Examples of benefits that you may directly feel after a few weeks of supplementation include improvements in mood and well-being, increased mental clarity, reduced muscle soreness and better joint health.

Just how strongly these effects are experienced largely depends on what your EPA/DHA levels were prior to supplementation, as well as individual factors.

Examples of benefits that you won’t necessarily “feel” but may experience symptoms of longer term include improved heart health, body composition, immune function and bone health just to name a few.

Yes

No

No

1.The Preventable Causes of Death in the United States: Comparative Risk Assessment of Dietary, Lifestyle, and Metabolic Risk Factors.
Goodarz Danaei, Eric L. Ding, Dariush Mozaffarian, Ben Taylor, Jürgen Rehm, Christopher J. L. Murray, and Majid Ezzati. PLoS Med. 2009 Apr; 6(4): e1000058.

2.Global and regional causes of death.
Mathers CD, Boerma T, Ma Fat D. Br Med Bull. 2009;92:7-32.

3.The inverse relation between fish consumption and 20-year mortality from coronary heart disease.
Kromhout D, Bosschieter EB, de Lezenne Coulander C. N Engl J Med. 1985 May 9;312(19):1205-9

4.Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies.
He K, Song Y, Daviglus ML, Liu K, Van Horn L, Dyer AR, Greenland P. Circulation. 2004 Jun 8;109(22):2705-11.

5.Association between fish consumption, long chain omega 3 fatty acids, and risk of cerebrovascular disease: systematic review and meta-analysis.
Chowdhury R, Stevens S, Gorman D, Pan A, Warnakula S, Chowdhury S, Ward H, Johnson L, Crowe F, Hu FB, Franco OH. BMJ. 2012 Oct 30;345:e6698.

6.Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review.
Balk EM, Lichtenstein AH, Chung M, Kupelnick B, Chew P, Lau J. Atherosclerosis. 2006 Nov;189(1):19-30. Epub 2006 Mar 10.

7.Effect of fish oil supplementation on serum triglycerides, LDL cholesterol and LDL subfractions in hypertriglyceridemic adults.
Oelrich B, Dewell A, Gardner CD. Nutr Metab Cardiovasc Dis. 2013 Apr;23(4):350-7.

8.Effect of fish oil versus corn oil supplementation on LDL and HDL subclasses in type 2 diabetic patients.
Petersen M, Pedersen H, Major-Pedersen A, Jensen T, Marckmann P. Diabetes Care. 2002 Oct;25(10):1704-8.

9.Effect of fish oil supplementation on serum triglycerides, LDL cholesterol and LDL subfractions in hypertriglyceridemic adults.
Oelrich B, Dewell A, Gardner CD. Nutr Metab Cardiovasc Dis. 2013 Apr;23(4):350-7.

10.Benefits of fish oil supplementation in hyperlipidemia: a systematic review and meta-analysis.
Eslick GD, Howe PR, Smith C, Priest R, Bensoussan A. Int J Cardiol. 2009 Jul 24;136(1):4-16.

11.Low doses of eicosapentaenoic acid and docosahexaenoic acid from fish oil dose-dependently decrease serum triglyceride concentrations in the presence of plant sterols in hypercholesterolemic men and women.
Ras RT, Demonty I, Zebregs YE, Quadt JF, Olsson J, Trautwein EA. J Nutr. 2014 Oct;144(10):1564-70.

12.n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases.
Calder PC. Am J Clin Nutr. 2006 Jun;83(6 Suppl):1505S-1519S.

13.The role of inflammation in depression: from evolutionary imperative to modern treatment target.
Miller AH, Raison CL. Nat Rev Immunol. 2016 Jan;16(1):22-34.

14.Inflammation, Insulin Resistance, and Type 2 Diabetes: Back to the Future?
William T. Cefalu, Diabetes. 2009 Feb; 58(2): 307–308.

15.Consumption of Fish Oil Providing Amounts of Eicosapentaenoic Acid and Docosahexaenoic Acid That Can Be Obtained from the Diet Reduces Blood Pressure in Adults with Systolic Hypertension: A Retrospective Analysis.
Minihane AM, Armah CK, Miles EA, Madden JM, Clark AB, Caslake MJ, Packard CJ, Kofler BM, Lietz G, Curtis PJ, Mathers JC, Williams CM, Calder PC. J Nutr. 2016 Mar;146(3):516-23.

16.Does fish oil lower blood pressure? A meta-analysis of controlled trials. Morris MC, Sacks F, Rosner B. Circulation.
1993 Aug;88(2):523-33.

17.Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and blood pressure: a meta-analysis of randomized controlled trials.
Miller PE, Van Elswyk M, Alexander DD. Am J Hypertens. 2014 Jul;27(7):885-96.

18.Polyunsaturated fatty acids and their metabolites in brain function and disease.
Bazinet RP, Layé S. Nat Rev Neurosci. 2014 Dec;15(12):771-85.

19.Improved working memory but no effect on striatal vesicular monoamine transporter type 2 after omega-3 polyunsaturated fatty acid supplementation.
Narendran R, Frankle WG, Mason NS, Muldoon MF, Moghaddam B. PLoS One. 2012;7(10):e46832.

20.Serum phospholipid docosahexaenonic acid is associated with cognitive functioning during middle adulthood.
Muldoon MF, Ryan CM, Sheu L, Yao JK, Conklin SM, Manuck SB. J Nutr. 2010 Apr;140(4):848-53.

21.Fish consumption, n-3 fatty acids, and subsequent 5-y cognitive decline in elderly men: the Zutphen Elderly Study.
van Gelder BM, Tijhuis M, Kalmijn S, Kromhout D. Am J Clin Nutr. 2007 Apr;85(4):1142-7.

22.Fish consumption and cognitive decline with age in a large community study.
Morris MC, Evans DA, Tangney CC, Bienias JL, Wilson RS. Arch Neurol. 2005 Dec;62(12):1849-53. Epub 2005 Oct 10.

23.Cognitive performance among the elderly and dietary fish intake: the Hordaland Health Study.
Nurk E1, Drevon CA, Refsum H, Solvoll K, Vollset SE, Nygård O, Nygaard HA, Engedal K, Tell GS, Smith AD. Am J Clin Nutr. 2007 Nov;86(5):1470-8.

24.Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.
Amminger GP, Schäfer MR, Papageorgiou K, Klier CM, Cotton SM, Harrigan SM, Mackinnon A, McGorry PD, Berger GE. Arch Gen Psychiatry. 2010 Feb;67(2):146-54.

25.Longer-term outcome in the prevention of psychotic disorders by the Vienna omega-3 study.
Amminger GP, Schäfer MR, Schlögelhofer M, Klier CM, McGorry PD. Nat Commun. 2015 Aug 11;6:7934.

26.Essential fatty acid deficiency in erythrocyte membranes from chronic schizophrenic patients, and the clinical effects of dietary supplementation.
Peet M, Laugharne JD, Mellor J, Ramchand CN. Prostaglandins Leukot Essent Fatty Acids. 1996 Aug;55(1-2):71-5.

27.Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients.
Maes M, Christophe A, Delanghe J, Altamura C, Neels H, Meltzer HY. Psychiatry Res. 1999 Mar 22;85(3):275-91.

28.Investigating the inflammatory phenotype of major depression: focus on cytokines and polyunsaturated fatty acids.
Dinan T, Siggins L, Scully P, O’Brien S, Ross P, Stanton C. J Psychiatr Res. 2009 Jan;43(4):471-6.

29.Plasma fatty acid composition and depression are associated in the elderly: the Rotterdam Study.
Tiemeier H, van Tuijl HR, Hofman A, Kiliaan AJ, Breteler MM. Am J Clin Nutr. 2003 Jul;78(1):40-6.

30.Omega-3 polyunsaturated fatty acid (PUFA) status in major depressive disorder with comorbid anxiety disorders.
Liu JJ, Galfalvy HC, Cooper TB, Oquendo MA, Grunebaum MF, Mann JJ, Sublette ME. J Clin Psychiatry. 2013 Jul;74(7):732-8.

31.Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation
da Silva TM, Munhoz RP, Alvarez C, Naliwaiko K, Kiss A, Andreatini R, Ferraz AC. J Affect Disord. 2008 Dec;111(2-3):351-9.

32.Omega-3 fatty acids in major depressive disorder.
A preliminary double-blind, placebo-controlled trial. Su KP, Huang SY, Chiu CC, Shen WW. Eur Neuropsychopharmacol. 2003 Aug;13(4):267-71.

33.Short-term supplementation of acute long-chain omega-3 polyunsaturated fatty acids may alter depression status and decrease symptomology among young adults with depression: A preliminary randomized and placebo controlled trial.
Ginty AT1, Conklin SM2. Psychiatry Res. 2015 Sep 30;229(1-2):485-9.

34.Polyunsaturated fatty acids and their relation with bone and muscle health in adults.
Mangano KM, Sahni S, Kerstetter JE, Kenny AM, Hannan MT. Curr Osteoporos Rep. 2013 Sep;11(3):203-12.

35.Fatty acid profile in patients with phenylketonuria and its relationship with bone mineral density.
Lage S, Bueno M, Andrade F, Prieto JA, Delgado C, Legarda M, Sanjurjo P, Aldámiz-Echevarría LJ. J Inherit Metab Dis. 2010 Dec;33 Suppl 3:S363-71.

36.n−3 Fatty acids are positively associated with peak bone mineral density and bone accrual in healthy men: the NO2 Study.
Magnus Högström, Peter Nordström, and Anna Nordström. Am J Clin Nutr March 2007 vol. 85 no. 3 803-807.

37.Supplemental fish oil decreases urinary excretion of a marker of bone resorption in healthy adults.
Eric E Noreen, Josef Brandauer, Megan H MacNabb. J Int Soc Sports Nutr. 2011; 8(Suppl 1): P14.

38.DHA-enriched fish oil targets B cell lipid microdomains and enhances ex vivo and in vivo B cell function.
Eric A. Gurzell, Heather Teague, Mitchel Harris, Jonathan Clinthorne. April 2013 Journal of Leukocyte Biology vol. 93 no. 4 463-470.

39.Fish oil supplementation augments post-exercise immune function in young males.
Gray P, Gabriel B, Thies F, Gray SR. Brain Behav Immun. 2012 Nov;26(8):1265-72.

40.Influence of fish oil supplementation and strength training on some functional aspects of immune cells in healthy elderly women.
de Lourdes Nahhas Rodacki C, Rodacki AL, Coelho I, Pequito D, Krause M, Bonatto S, Naliwaiko K, Fernandes LC. Br J Nutr. 2015 Jul 14;114(1):43-52.

41.Metabolism of polyunsaturated fatty acids by skin epidermal enzymes: generation of antiinflammatory and antiproliferative metabolites.
Ziboh VA, Miller CC, Cho Y. Am J Clin Nutr. 2000 Jan;71(1 Suppl):361S-6S.

42.A double-blind, randomised, placebo-controlled trial of fish oil in psoriasis.
Bittiner SB, Tucker WF, Cartwright I, Bleehen SS. Lancet. 1988 Feb 20;1(8582):378-80.

43.A low-fat diet supplemented with dietary fish oil (Max-EPA) results in improvement of psoriasis and in formation of leukotriene B5.
Kragballe K, Fogh K. Acta Derm Venereol. 1989;69(1):23-8.

44.Circulating omega-3 Fatty acids and neovascular age-related macular degeneration.
Merle BM, Benlian P, Puche N, Bassols A, Delcourt C, Souied EH; Nutritional AMD Treatment 2 Study Group. Invest Ophthalmol Vis Sci. 2014 Mar 28;55(3):2010-9.

45.High concentrations of plasma n3 fatty acids are associated with decreased risk for late age-related macular degeneration.
Merle BM, Delyfer MN, Korobelnik JF, Rougier MB, Malet F, Féart C, Le Goff M, Peuchant E, Letenneur L, Dartigues JF, Colin J, Barberger-Gateau P, Delcourt C. J Nutr. 2013 Apr;143(4):505-11.

46.Effect of fish oil on heart rate in humans: a meta-analysis of randomized controlled
Mozaffarian D, Geelen A, Brouwer IA, Geleijnse JM, Zock PL, Katan MB. Circulation. 2005 Sep 27;112(13):1945-52. Epub 2005 Sep 19.

47.Omega-3 polyunsaturated fatty acids augment the muscle protein anabolic response to hyperinsulinaemia-hyperaminoacidaemia in healthy young and middle-aged men and women.
Smith GI, Atherton P, Reeds DN, Mohammed BS, Rankin D, Rennie MJ, Mittendorfer B. Clin Sci (Lond). 2011 Sep;121(6):267-78.

48.Dietary omega-3 fatty acid supplementation increases the rate of muscle protein synthesis in older adults: a randomized controlled trial.
Smith GI, Atherton P, Reeds DN, Mohammed BS, Rankin D, Rennie MJ, Mittendorfer B. Am J Clin Nutr. 2011 Feb;93(2):402-12.

49.The anti-catabolic effects of n-3 fatty acids.
Ross JA, Moses AG, Fearon KC. Curr Opin Clin Nutr Metab Care. 1999 May;2(3):219-26.

50.Downregulation of ubiquitin-dependent proteolysis by eicosapentaenoic acid in acute starvation.
Whitehouse AS, Tisdale MJ. Biochem Biophys Res Commun. 2001 Jul 20;285(3):598-602.

51.Fish oil prevents the adrenal activation elicited by mental stress in healthy men.
Delarue J, Matzinger O, Binnert C, Schneiter P, Chioléro R, Tappy L. Diabetes Metab. 2003 Jun;29(3):289-95.

52.Effects of supplemental fish oil on resting metabolic rate, body composition, and salivary cortisol in healthy adults.
Eric E Noreen, Michael J Sass, Megan L Crowe, Vanessa A Pabon, Josef Brandauer and Lindsay K Averill. Journal of the International Society of Sports Nutrition 2010 7:31.

53.Combining fish-oil supplements with regular aerobic exercise improves body composition and cardiovascular disease risk factors.
Hill AM, Buckley JD, Murphy KJ, Howe PR. Am J Clin Nutr. 2007 May;85(5):1267-74.

54.Randomized trial of weight-loss-diets for young adults varying in fish and fish oil content.
Thorsdottir I, Tomasson H, Gunnarsdottir I, Gisladottir E, Kiely M, Parra MD, Bandarra NM, Schaafsma G, Martinéz JA. Int J Obes (Lond). 2007 Oct;31(10):1560-6. Epub 2007 May 15.

55.Anti-obesity effects of long-chain omega-3 polyunsaturated fatty acids.
Buckley JD, Howe PR. Obes Rev. 2009 Nov;10(6):648-59.

56.Effect of dietary fish oil on body fat mass and basal fat oxidation in healthy adults.
Couet C, Delarue J, Ritz P, Antoine JM, Lamisse F. Int J Obes Relat Metab Disord. 1997 Aug;21(8):637-43.

57.High omega-3 fat intake improves insulin sensitivity and reduces CRP and IL6, but does not affect other endocrine axes in healthy older adults.
Tsitouras PD, Gucciardo F, Salbe AD, Heward C, Harman SM. Horm Metab Res. 2008 Mar;40(3):199-205.

58.Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins.
González-Périz A, Horrillo R, Ferré N, Gronert K, Dong B, Morán-Salvador E, Titos E, Martínez-Clemente M, López-Parra M, Arroyo V, Clària J. FASEB J. 2009 Jun;23(6):1946-57.

59.The effects of ingestion of omega-3 fatty acids on perceived pain and external symptoms of delayed onset muscle soreness in untrained men.
Tartibian B, Maleki BH, Abbasi A. Clin J Sport Med. 2009 Mar;19(2):115-9.

60.Effects of Fish Oil Supplementation on Postresistance Exercise Muscle Soreness.
Tinsley GM, Gann JJ, Huber SR, Andre TL, La Bounty PM, Bowden RG, Gordon PM, Grandjean PW. J Diet Suppl. 2016 Jul 21:1-12.

61.A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain.
Goldberg RJ, Katz J. Pain. 2007 May;129(1-2):210-23. Epub 2007 Mar 1.

62.Polyunsaturated fatty acids in the food chain in the United States.
Kris-Etherton PM, Taylor DS, Yu-Poth S, Huth P, Moriarty K, Fishell V, Hargrove RL, Zhao G, Etherton TD. Am J Clin Nutr. 2000 Jan;71(1 Suppl):179S-88S.

63.Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases
Simopoulos AP. Biomed Pharmacother. 2006 Nov;60(9):502-7. Epub 2006 Aug 28.

64.Enhanced increase of omega-3 index in response to long-term n-3 fatty acid supplementation from triacylglycerides versus ethyl esters.
Neubronner J, Schuchardt JP, Kressel G, Merkel M, von Schacky C, Hahn A. Eur J Clin Nutr. 2011 Feb;65(2):247-54.

65.Comparative bioavailability of eicosapentaenoic acid and docasahexaenoic acid from triglycerides, free fatty acids and ethyl esters in volunteers.
Beckermann B, Beneke M, Seitz I. Arzneimittelforschung. 1990 Jun;40(6):700-4.

66.Human absorption of fish oil fatty acids as triacylglycerols, free acids, or ethyl esters.
Lawson LD, Hughes BG. Biochem Biophys Res Commun. 1988 Apr 15;152(1):328-35.

67.Analysis of Headspace Volatile and Oxidized Volatile Compounds in DHA-enriched Fish Oil on Accelerated Oxidative Storage.
Lawson LD, Hughes BG. Biochem Biophys Res Commun. 1988 Apr 15;152(1):328-35.

68.Bioavailability of marine n-3 fatty acid formulations.
Dyerberg J, Madsen P, Møller JM, Aardestrup I, Schmidt EB. Prostaglandins Leukot Essent Fatty Acids. 2010 Sep;83(3):137-41.

69.Moderate doses of EPA and DHA from re-esterified triacylglycerols but not from ethyl-esters lower fasting serum triacylglycerols in statin-treated dyslipidemic subjects: Results from a six month randomized controlled trial.
Schuchardt JP, Neubronner J, Kressel G, Merkel M, von Schacky C, Hahn A. Prostaglandins Leukot Essent Fatty Acids. 2011 Dec;85(6):381-6.

70.Oxidative stability of docosahexaenoic acid-containing oils in the form of phospholipids, triacylglycerols, and ethyl esters.
Song JH, Inoue Y, Miyazawa T. Biosci Biotechnol Biochem. 1997 Dec;61(12):2085-8.

71.Evaluation of the global impacts of mitigation on persistent, bioaccumulative and toxic pollutants in marine fish.
Bonito LT, Hamdoun A, Sandin SA. PeerJ. 2016 Jan 28;4:e1573.

72.Persistent, bioaccumulative and toxic substances in fish: human health considerations.
Dórea JG. Sci Total Environ. 2008 Aug 1;400(1-3):93-114.

73.Persistent organic pollutants in fish oil supplements on the Canadian market: polychlorinated biphenyls and organochlorine insecticides.
Rawn DF, Breakell K, Verigin V, Nicolidakis H, Sit D, Feeley M. J Food Sci. 2009 Jan-Feb;74(1):T14-9.

74.Polychlorinated biphenyls (PCBs) contamination and aryl hydrocarbon receptor (AhR) agonist activity of Omega-3 polyunsaturated fatty acid supplements: implications for daily intake of dioxins and PCBs.
Bourdon JA, Bazinet TM, Arnason TT, Kimpe LE, Blais JM, White PA. Food Chem Toxicol. 2010 Nov;48(11):3093-7.